CD8A and neoplasm: Many different types of lymphocytes have been identified in the TME (CD4+ with/without suppressor FoxP3+ expression, CD8+ with/without PD-L1 expression, and M2 macrophages) [53,54], reflecting the complex interplay between tumor antigenicity and host immune reaction.